NCT02357342View on ClinicalTrials.gov

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Sirolimus

intravitreal injection

DRUG

Standard of Care intravitreal injections of anti-VEGF

intravitreal injections of anti-VEGF

Trial Locations (1)

46290

Raj K Maturi MD PC, Indianapolis

All Listed Sponsors
lead

Maturi, Raj K., M.D., P.C.

INDIV

NCT02357342 - Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD | Biotech Hunter | Biotech Hunter